Complement factor D antagonist antibodies and conjugates thereof
US11584790B2 · kind B2 · utility
4Cited by
70References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2018 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | Nov 12, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21046
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.